Tarsus Pharmaceuticals, Inc.

TARS·NASDAQ·$61.16Share Price as of 11/2·$3BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/06/26 10-KFY 202502/23/26 10-QQ3 ended 09/30/2511/04/25 10-QQ2 ended 06/30/2508/06/25

Disclosures

8-K/ACurrent report (amended)10/13/26 8-KCurrent report09/10/26 8-KCurrent report08/06/26 8-KCurrent report08/06/26 8-KCurrent report08/06/26

Prospectuses and Registrations

S-3ASRAutomatic shelf registration10/13/26 S-3ASRAutomatic shelf registration10/13/26 S-8Registration of securities for employees02/23/26 424B5Prospectus supplement03/13/25 424B5Prospectus supplement03/12/25

Proxies

DEF 14ADefinitive proxy04/28/26 DEFA14AAdditional proxy materials04/28/26 DEF 14ADefinitive proxy04/28/25 DEFA14AAdditional proxy materials04/28/25 DEF 14ADefinitive proxy04/26/24

Ownership

Form 4Insider transaction09/17/26 Form 4Insider transaction09/17/26 Form 4Insider transaction09/17/26 144Proposed sale of securities09/15/26 Form 4Insider transaction09/09/26

Other

ARSAnnual report to shareholders04/28/26 ARSAnnual report to shareholders04/28/25 ARSAnnual report to shareholders04/26/24 EFFECTRequest for effectiveness11/21/23 CORRESPCorrespondence with the SEC11/17/23